Mulmit

Organon & Co.Organon & Co.

OGN NYSE

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-316,216,000,000187,000,0000.72
2024-12-316,403,000,000864,000,0003.33
2023-12-316,263,000,0001,023,000,0003.99
2022-12-316,174,000,000917,000,0003.59
2021-12-316,304,000,0001,351,000,0005.31

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-11Arjona Ferreira Juan CamiloHead of R&D & CMO11,519
2026-08-11Arjona Ferreira Juan CamiloHead of R&D & CMO4,134
2026-08-11Arjona Ferreira Juan CamiloHead of R&D & CMO11,519
2026-08-05Drinane Juliana PapaHead of Mfg & Supply14,761
2026-06-12Sharp Shalini17,857
2026-06-12Sequeira Ramona17,857
2026-06-12Patton Cynthia M17,857
2026-06-12Ozuah Philip17,857
2026-06-12Leone Deborah R17,857
2026-06-12LAZARUS ROCHELLE B17,857
2026-06-12Gayle Helene D17,857
2026-06-12Ezekowitz Alan17,857

8-K events

FiledItems
2026-07-31Regulation FD disclosure · Financial statements and exhibits
2026-07-23Submission of matters to a vote
2026-07-17Other events
2026-06-11Officer or director change · Submission of matters to a vote · Financial statements and exhibits
2026-04-30Results of operations · Financial statements and exhibits
2026-04-27Entry into a material agreement · Officer or director change · Regulation FD disclosure · Financial statements and exhibits
2026-02-20Other events · Financial statements and exhibits
2026-02-12Results of operations · Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.